Astrana Health Inc. (ASTH)
NASDAQ:ASTH
ASTH Stock Chart & Stats
$18.59
$0.06(0.19%)
At close: 4:00 PM EST
$18.59
$0.06(0.19%)
Day’s Range― - ―
52-Week Range$18.08 - $34.80
Previous CloseN/A
Volume92.25K
Average Volume (3M)512.03K
Market Cap
$1.22B
Enterprise Value$1.87B
Total Cash (Recent Filing)$429.47M
Total Debt (Recent Filing)$1.08B
Price to Earnings (P/E)54.1
Beta0.97
Next Earnings
May 13, 2026EPS Estimate
0.3Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding50,155,613
10 Day Avg. Volume452,544
30 Day Avg. Volume512,028
Financial Highlights & Ratios
PEG Ratio-1.09
Price to Book (P/B)1.56
Price to Sales (P/S)0.38
P/FCF Ratio11.65
Enterprise Value/Market Cap1.53
Enterprise Value/Revenue0.59
Enterprise Value/Gross Profit6.03
Enterprise Value/Ebitda14.50
Forecast
1Y Price Target
$33.80Price Target Upside81.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
EPS Forecast (FY)1.24
Revenue Forecast (FY)$3.99B
Bulls Say, Bears Say
Bulls Say
Acquisition SynergiesRealization of synergies from the Prospect Health acquisition together with automation-driven efficiencies should lift margins and reinforce growth assumptions.
EarningsAdjusted EBITDA exceeded analyst consensus because Care Partners and delivery services drove stronger revenues, supporting improving operating profitability.
Revenue QualityProgress toward receiving most revenue through fully capitated contracts is expected to improve revenue predictability and overall earnings quality.
Bears Say
Governance And ReportingExtension of the annual report filing due to timing and documentation of control procedures has raised investor scrutiny on governance practices and could weigh on sentiment.
Guidance RiskManagement issued guidance below analyst expectations and provided a bridge that implies downside if bridging items underperform, increasing execution risk for results.
Payer And Enrollment HeadwindsMedicaid disenrollment pressures and the loss of a California funding source create revenue headwinds and heighten the need for disciplined cost control.
Astrana Health News
ASTH FAQ
What was Astrana Health Inc.’s price range in the past 12 months?
Astrana Health Inc. lowest stock price was $18.08 and its highest was $34.80 in the past 12 months.
What is Astrana Health Inc.’s market cap?
Astrana Health Inc.’s market cap is $1.22B.
When is Astrana Health Inc.’s upcoming earnings report date?
Astrana Health Inc.’s upcoming earnings report date is May 13, 2026 which is in 47 days.
How were Astrana Health Inc.’s earnings last quarter?
Astrana Health Inc. released its earnings results on Mar 04, 2026. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.106 by $0.014.
Is Astrana Health Inc. overvalued?
According to Wall Street analysts Astrana Health Inc.’s price is currently Undervalued.
Does Astrana Health Inc. pay dividends?
Astrana Health Inc. does not currently pay dividends.
What is Astrana Health Inc.’s EPS estimate?
Astrana Health Inc.’s EPS estimate is 0.3.
How many shares outstanding does Astrana Health Inc. have?
Astrana Health Inc. has 50,155,613 shares outstanding.
What happened to Astrana Health Inc.’s price movement after its last earnings report?
Astrana Health Inc. reported an EPS of $0.12 in its last earnings report, beating expectations of $0.106. Following the earnings report the stock price went up 4.406%.
Which hedge fund is a major shareholder of Astrana Health Inc.?
Currently, no hedge funds are holding shares in ASTH
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Astrana Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$33.80 (81.82% Upside)
$33.80 (81.82% Upside)
Blogger Sentiment
Bullish
ASTH Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 184.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 3.9%
Last 30 Days ▼ 7.1%
Last 30 Days ▼ 7.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.49%
12-Months-Change
Fundamentals
Return on Equity
2.93%
Trailing 12-Months
Asset Growth
63.48%
Trailing 12-Months
Company Description
Astrana Health Inc.
Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.
ASTH Company Deck
ASTH Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized multiple record financial and operating milestones—strong double‑digit top-line growth, record adjusted EBITDA and free cash flow, expanding geographic diversification, measurable operating leverage from the platform and AI, and progressing integration synergies from the Prospect acquisition. Management acknowledged near-term headwinds including a material weakness in controls (Form 12b-25), elevated 2026 cost assumptions, Medicaid/exchange disenrollment risk, transaction-related one-time costs, and leverage that create measurable but manageable risk. Guidance is framed conservatively with clear paths to the midpoint driven by realized synergies, ramping full-risk contracts, and AI-driven efficiencies.View all ASTH earnings summariesASTH Stock 12 Month Forecast
Average Price Target
$33.80
▲(81.82% Upside)
Technical Analysis
Healthcare Services
―
Pediatrix Medical Group
―
Select Medical
―
US Physical Therapy
―
Aveanna Healthcare Holdings
―
Ownership Overview
35.09% Insiders
16.75% Mutual Funds
11.69% Other Institutional Investors
15.03% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---